Sandipkumar S. Kapadia
Financieel Directeur/CFO bij HARMONY BIOSCIENCES HOLDINGS, INC.
Vermogen: - $ op 30-04-2024
Momenteel actieve connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Patrick Amstutz | M | 49 |
Molecular Partners, Inc.
Molecular Partners, Inc. Pharmaceuticals: MajorHealth Technology Part of Molecular Partners AG, Molecular Partners, Inc. operates as a clinical-stage biopharmaceutical company. The company is based in Cambridge, MA. The CEO of the company is Patrick Amstutz. | 20 jaar |
Stephen P. Squinto | M | 67 |
VectivBio AG
VectivBio AG BiotechnologyHealth Technology VectivBio AG is a clinical-stage biotechnology company. The firm focuses on developing transformational therapeutics for patients living with serious and rare diseases. Its program apraglutide, is a next-generation GLP-2 analog for the treatment of short bowel syndrome (SBS). The company was founded by Luca Santarelli in 2019 and is headquartered in Basel, Switzerland. | 6 jaar |
Michael Tobias Stumpp | M | 52 |
Molecular Partners, Inc.
Molecular Partners, Inc. Pharmaceuticals: MajorHealth Technology Part of Molecular Partners AG, Molecular Partners, Inc. operates as a clinical-stage biopharmaceutical company. The company is based in Cambridge, MA. The CEO of the company is Patrick Amstutz. | 20 jaar |
Thomas Woiwode | M | 52 |
VectivBio AG
VectivBio AG BiotechnologyHealth Technology VectivBio AG is a clinical-stage biotechnology company. The firm focuses on developing transformational therapeutics for patients living with serious and rare diseases. Its program apraglutide, is a next-generation GLP-2 analog for the treatment of short bowel syndrome (SBS). The company was founded by Luca Santarelli in 2019 and is headquartered in Basel, Switzerland. | 6 jaar |
Jeffrey Dayno | M | 66 | 7 jaar | |
William Burns | M | 76 |
Molecular Partners, Inc.
Molecular Partners, Inc. Pharmaceuticals: MajorHealth Technology Part of Molecular Partners AG, Molecular Partners, Inc. operates as a clinical-stage biopharmaceutical company. The company is based in Cambridge, MA. The CEO of the company is Patrick Amstutz. | 7 jaar |
Jerome B. Durso | M | 56 | 7 jaar | |
Edgar Cale | M | 60 | 5 jaar | |
Chahra Khaoua Epouse Louafi | F | 53 |
VectivBio AG
VectivBio AG BiotechnologyHealth Technology VectivBio AG is a clinical-stage biotechnology company. The firm focuses on developing transformational therapeutics for patients living with serious and rare diseases. Its program apraglutide, is a next-generation GLP-2 analog for the treatment of short bowel syndrome (SBS). The company was founded by Luca Santarelli in 2019 and is headquartered in Basel, Switzerland. | 4 jaar |
Paul Carter | M | 63 |
VectivBio AG
VectivBio AG BiotechnologyHealth Technology VectivBio AG is a clinical-stage biotechnology company. The firm focuses on developing transformational therapeutics for patients living with serious and rare diseases. Its program apraglutide, is a next-generation GLP-2 analog for the treatment of short bowel syndrome (SBS). The company was founded by Luca Santarelli in 2019 and is headquartered in Basel, Switzerland. | 3 jaar |
Johannes G. C. P. Schikan | M | 66 |
VectivBio AG
VectivBio AG BiotechnologyHealth Technology VectivBio AG is a clinical-stage biotechnology company. The firm focuses on developing transformational therapeutics for patients living with serious and rare diseases. Its program apraglutide, is a next-generation GLP-2 analog for the treatment of short bowel syndrome (SBS). The company was founded by Luca Santarelli in 2019 and is headquartered in Basel, Switzerland. | 5 jaar |
Michael Vasconcelles | M | 61 |
Molecular Partners, Inc.
Molecular Partners, Inc. Pharmaceuticals: MajorHealth Technology Part of Molecular Partners AG, Molecular Partners, Inc. operates as a clinical-stage biopharmaceutical company. The company is based in Cambridge, MA. The CEO of the company is Patrick Amstutz. | 4 jaar |
William Chou | M | 51 | 2 jaar | |
Murray Stewart | M | 63 |
VectivBio AG
VectivBio AG BiotechnologyHealth Technology VectivBio AG is a clinical-stage biotechnology company. The firm focuses on developing transformational therapeutics for patients living with serious and rare diseases. Its program apraglutide, is a next-generation GLP-2 analog for the treatment of short bowel syndrome (SBS). The company was founded by Luca Santarelli in 2019 and is headquartered in Basel, Switzerland. | 3 jaar |
Vito Palombella | M | 61 |
Molecular Partners, Inc.
Molecular Partners, Inc. Pharmaceuticals: MajorHealth Technology Part of Molecular Partners AG, Molecular Partners, Inc. operates as a clinical-stage biopharmaceutical company. The company is based in Cambridge, MA. The CEO of the company is Patrick Amstutz. | 4 jaar |
Luca Santarelli | M | 55 |
VectivBio AG
VectivBio AG BiotechnologyHealth Technology VectivBio AG is a clinical-stage biotechnology company. The firm focuses on developing transformational therapeutics for patients living with serious and rare diseases. Its program apraglutide, is a next-generation GLP-2 analog for the treatment of short bowel syndrome (SBS). The company was founded by Luca Santarelli in 2019 and is headquartered in Basel, Switzerland. | 5 jaar |
Steven Holtzman | M | 70 |
Molecular Partners, Inc.
Molecular Partners, Inc. Pharmaceuticals: MajorHealth Technology Part of Molecular Partners AG, Molecular Partners, Inc. operates as a clinical-stage biopharmaceutical company. The company is based in Cambridge, MA. The CEO of the company is Patrick Amstutz. | 10 jaar |
Maxine Gowen | M | 66 | 3 jaar | |
Linda Szyper | F | 58 | 3 jaar | |
James M. Wilson | M | - | 7 jaar | |
Derrell Porter | M | 53 | 3 jaar | |
Jeffrey Aronin | M | 56 | 7 jaar | |
Jared M. Freedberg | M | 55 | 3 jaar | |
Daniel Steiner | M | - | 13 jaar | |
Lisa Bright | F | 56 |
Intercept Pharma Europe Ltd.
Intercept Pharma Europe Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2014, Intercept Pharma Europe Ltd. is a subsidiary of Intercept Pharmaceuticals, Inc. that researches, develops, and sells pharmaceutical products. The company is based in Bristol, UK. | 10 jaar |
Jeffrey Dierks | M | 52 | 7 jaar | |
Ulrich Christian | M | - | 3 jaar | |
Sharon Goldbach | F | - | - | |
Dominik Höchli | M | 57 | 3 jaar | |
Kathleen Borthwick | F | 48 | 3 jaar | |
Daniel Carey Cazel Hood | M | 51 |
Intercept Pharma Europe Ltd.
Intercept Pharma Europe Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2014, Intercept Pharma Europe Ltd. is a subsidiary of Intercept Pharmaceuticals, Inc. that researches, develops, and sells pharmaceutical products. The company is based in Bristol, UK. | - |
Kumar Budur | M | 53 | - | |
R. Graf | M | 59 | 4 jaar | |
Athena Countouriotis | M | 52 | 4 jaar | |
Stuart M. Henderson | M | - | 3 jaar | |
Saqib Islam | M | 54 | 5 jaar | |
Jack Nielsen | M | 60 | 7 jaar | |
Andreas Wicki | M | 64 | 7 jaar | |
Seth D. Lewis | M | - | 5 jaar | |
Agnete Brunsvik Fredriksen | M | 47 | 3 jaar | |
Juan Sabater | M | 59 | 7 jaar | |
Gwen A. Fyfe | M | 72 |
Molecular Partners, Inc.
Molecular Partners, Inc. Pharmaceuticals: MajorHealth Technology Part of Molecular Partners AG, Molecular Partners, Inc. operates as a clinical-stage biopharmaceutical company. The company is based in Cambridge, MA. The CEO of the company is Patrick Amstutz. | 5 jaar |
Andreas Emmenegger | M | 58 |
Molecular Partners, Inc.
Molecular Partners, Inc. Pharmaceuticals: MajorHealth Technology Part of Molecular Partners AG, Molecular Partners, Inc. operates as a clinical-stage biopharmaceutical company. The company is based in Cambridge, MA. The CEO of the company is Patrick Amstutz. | 17 jaar |
Gary Sender | M | 62 | 4 jaar | |
Peter Anastasiou | M | 53 | 1 jaar | |
Antonio Gracias | M | 53 | 7 jaar | |
Renate Gloggner | F | - | 3 jaar | |
Cate McCanless | F | - | - | |
Michael Pitzner | M | - | 2 jaar | |
Philippe Legenne | M | - | 4 jaar | |
Luis Sanay | M | - | 2 jaar | |
Alexander Zürcher | M | - | 2 jaar | |
Dolan Sondhi | M | 53 | 1 jaar | |
Mark Forman | M | 60 | 3 jaar | |
Andrew Serafin | M | 49 | 7 jaar | |
Audrey Murphy | F | - | - | |
Andrea Campanile | F | - | - | |
Brant Schofield | M | - |
Sandoz, Inc.
Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ. | 8 jaar |
Linda M. Richardson | F | 60 | 6 jaar | |
Christian Meyer | M | 56 |
VectivBio AG
VectivBio AG BiotechnologyHealth Technology VectivBio AG is a clinical-stage biotechnology company. The firm focuses on developing transformational therapeutics for patients living with serious and rare diseases. Its program apraglutide, is a next-generation GLP-2 analog for the treatment of short bowel syndrome (SBS). The company was founded by Luca Santarelli in 2019 and is headquartered in Basel, Switzerland. | - |
Mark Pruzanski | M | 56 |
Intercept Pharma Europe Ltd.
Intercept Pharma Europe Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2014, Intercept Pharma Europe Ltd. is a subsidiary of Intercept Pharmaceuticals, Inc. that researches, develops, and sells pharmaceutical products. The company is based in Bristol, UK. | - |
Baris Arican | M | - | 2 jaar | |
Alex Fotopoulos | M | 55 | 5 jaar | |
Tricia Glover | F | - | - | |
David Bradshaw | M | 62 | - |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
John Jacobs | M | 57 | 6 jaar | |
Bruce Goldsmith | M | 58 | 2 jaar | |
Jonathan Silverstein | M | 57 | 7 jaar | |
Klaus Veitinger | M | 62 | 4 jaar | |
Mark Vignola | M | 47 | 4 jaar | |
Patrick Malloy | M | - | - | |
Wouter Joustra | M | 35 | 1 jaar | |
Bryan Ball | M | 54 | 1 jaar | |
Bryan Yoon | M | 46 | 4 jaar | |
Nancy Miller-Rich | F | 65 | 5 jaar | |
Michael Kamarck | M | 73 | 1 jaar | |
Scott Applebaum | M | 57 | - | |
Eric L. Motley | M | 51 | 1 jaar | |
Keith Gottesdiener | M | 70 | 7 jaar | |
Göran Albert Ando | M | 75 | 10 jaar | |
Daniel Bradbury | M | 62 | 7 jaar | |
Tadataka Yamada | M | 77 | 4 jaar | |
Patrick Heron | M | 53 | 3 jaar | |
Liam Ratcliffe | M | 60 | 3 jaar | |
Ryan Sullivan | M | 48 | 2 jaar | |
Nicolas Leupin | M | 50 | 4 jaar | |
Jason A. Campagna | M | 54 | 2 jaar | |
Monika Tornsen | F | 45 | 1 jaar | |
Brian Burkavage | M | - | 1 jaar | |
Julien Gander | M | 45 | 6 jaar | |
Sarah Holland | F | 61 | 2 jaar | |
Susan Drexler | F | 54 | 2 jaar | |
Gary Romano | M | 63 | 2 jaar | |
Eliseo Salinas | M | 69 | 1 jaar | |
William Lee | M | 69 | 13 jaar | |
Gwendolyn Fisher | F | - | 2 jaar | |
Simona King | F | 52 | 2 jaar | |
Desiree Luthman | M | 65 | 3 jaar | |
Jill Quigley | F | 49 | 3 jaar | |
Ingrid Delaet | M | 58 | 5 jaar |
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
Verenigde Staten | 75 | 75.00% |
Zwitserland | 33 | 33.00% |
Verenigd Koninkrijk | 3 | 3.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Sandipkumar S. Kapadia
- Persoonlijk netwerk